US Dollar vs Yen

登録して、同じ考えを持つ投資家と議論するためのアクティブなフォーラムで相互作用するためのアクティブなフォーラムに参加してください。

登録

ホーム
投資
株式
アメリカ
NASDAQ
Incyte Corporation (INCY)
Incyte Corporation (INCY) ニュース

INCY

Incyte (INCY)

Incyte Corporation

から:

Regulatory News

Text Search:

次の項目別のソート:

Non-Regulatory News

Showing the most relevant articles for your search:NASDAQ:INCY

1 2 3 4 5 6 7 8 9 10 次へ >>

日付	受信時刻	ニュースソース	見出し	コード	企業名
2024/06/13	05 : 59	Edgar (US Regulatory)	Form 144 - Report of proposed sale of securities	NASDAQ:INCY	Incyte Corporation
2024/06/11	21 : 16	Edgar (US Regulatory)	Form SC TO-I/A - Tender offer statement by Issuer: [Amend]	NASDAQ:INCY	Incyte Corporation
2024/06/11	21 : 00	Business Wire	Incyte Announces Preliminary Results of Tender Offer	NASDAQ:INCY	Incyte Corporation
2024/06/11	01 : 25	Edgar (US Regulatory)	Form 4 - Statement of changes in beneficial ownership of securities	NASDAQ:INCY	Incyte Corporation
2024/06/08	05 : 30	Business Wire	Incyte Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)	NASDAQ:INCY	Incyte Corporation
2024/06/07	05 : 40	Edgar (US Regulatory)	Form 144 - Report of proposed sale of securities	NASDAQ:INCY	Incyte Corporation
2024/06/05	06 : 29	Edgar (US Regulatory)	Form SC TO-I/A - Tender offer statement by Issuer: [Amend]	NASDAQ:INCY	Incyte Corporation
2024/05/31	05 : 05	Business Wire	Incyte Completes Acquisition of Escient Pharmaceuticals	NASDAQ:INCY	Incyte Corporation
2024/05/31	04 : 12	Edgar (US Regulatory)	Form DEFA14A - Additional definitive proxy soliciting materials and Rule 14(a)(12) material	NASDAQ:INCY	Incyte Corporation
2024/05/22	02 : 15	Business Wire	Incyte Expands Presence in Delaware through Acquisition of Two Downtown Wilmington Office Buildings	NASDAQ:INCY	Incyte Corporation
2024/05/21	21 : 00	Business Wire	Incyte to Present at Upcoming Investor Conference	NASDAQ:INCY	Incyte Corporation
2024/05/16	10 : 45	Business Wire	Incyte präsentiert Daten aus seinem Onkologie-Portfolio beim Jahrestreffen 2024 der ASCO und beim EHA2024 Congress	NASDAQ:INCY	Incyte Corporation
2024/05/16	00 : 44	Business Wire	Incyte présentera les données de son portefeuille d'oncologie lors de la réunion annuelle 2024 de l'ASCO et du congrès EHA2024	NASDAQ:INCY	Incyte Corporation
2024/05/16	00 : 10	Edgar (US Regulatory)	Form SC TO-I/A - Tender offer statement by Issuer: [Amend]	NASDAQ:INCY	Incyte Corporation
2024/05/15	06 : 00	Business Wire	Incyte to Highlight Data From its Oncology Portfolio at the 2024 ASCO Annual Meeting and EHA2024 Congress	NASDAQ:INCY	Incyte Corporation
2024/05/14	22 : 05	IH Market News	Producer Price Inflation Data May Weigh On Wall Street	NASDAQ:INCY	Incyte Corporation
2024/05/14	07 : 06	Edgar (US Regulatory)	Form SC 13D/A - General statement of acquisition of beneficial ownership: [Amend]	NASDAQ:INCY	Incyte Corporation
2024/05/14	05 : 34	IH Market News	Dow Snaps Eight-Day Winning Streak After Lackluster Session	NASDAQ:INCY	Incyte Corporation
2024/05/14	00 : 19	Edgar (US Regulatory)	Form SC TO-I - Tender offer statement by Issuer	NASDAQ:INCY	Incyte Corporation
2024/05/13	20 : 19	Edgar (US Regulatory)	Form SC TO-C - Written communication relating to an issuer or third party	NASDAQ:INCY	Incyte Corporation
2024/05/13	20 : 18	Edgar (US Regulatory)	Form 8-K - Current report	NASDAQ:INCY	Incyte Corporation
2024/05/13	20 : 00	Business Wire	Incyte Announces Intention to Buy Back up to $2.0 Billion of its Common Stock	NASDAQ:INCY	Incyte Corporation
2024/05/10	07 : 40	Edgar (US Regulatory)	Form SC 13D/A - General statement of acquisition of beneficial ownership: [Amend]	NASDAQ:INCY	Incyte Corporation
2024/05/10	07 : 25	Edgar (US Regulatory)	Form 4 - Statement of changes in beneficial ownership of securities	NASDAQ:INCY	Incyte Corporation
2024/05/02	21 : 00	Business Wire	Incyte to Present at Upcoming Investor Conference	NASDAQ:INCY	Incyte Corporation
2024/04/30	20 : 00	Business Wire	Incyte Reports 2024 First Quarter Financial Results and Provides Updates on Key Clinical Programs	NASDAQ:INCY	Incyte Corporation
2024/04/24	07 : 11	Business Wire	Incyte annonce l'acquisition d'Escient Pharmaceuticals et de son portefeuille d'antagonistes MRGPR oraux premiers de leur catégorie	NASDAQ:INCY	Incyte Corporation
2024/04/24	07 : 01	Business Wire	Incyte gibt Übernahme von Escient Pharmaceuticals und dessen Pipeline oraler First-in-Class-MRGPR-Antagonisten bekannt	NASDAQ:INCY	Incyte Corporation
2024/04/23	20 : 00	Business Wire	Incyte Announces Acquisition of Escient Pharmaceuticals and its Pipeline of First-in-Class Oral MRGPR Antagonists	NASDAQ:INCY	Incyte Corporation
2024/04/11	21 : 00	Business Wire	Incyte to Report First Quarter Financial Results	NASDAQ:INCY	Incyte Corporation

Showing the most relevant articles for your search:NASDAQ:INCY

1 2 3 4 5 6 7 8 9 10 次へ >>

Energy Select Sector SPDR

US Dollar vs Yen

Gold vs US Dollar

Health Care Select Sector

Bank of America

Delayed Upgrade Clock

顧客サポート: +44 (0) 203 8794 460 | support@advfn.com

ADVFNのサービスをご利用いただくには、利用規約